NL-OMON52371招募中不适用
The MOMENTUM Study - The Multiple OutcoMe EvaluatioN of radiation Therapy Using the MR-Linac - MOMENTUM
niversitair Medisch Centrum Utrecht0 个研究点目标入组 5,000 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 5,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •In order to be eligible to participate in this study, a subject must meet all
- •of the following criteria:
- •- Patient is to undergo or has completed imaging or treatment procedures on an
- •- Patient provides written, informed consent;
- •- Patient is 18 years old or older.
排除标准
- •MRI exclusion criteria, including
- •- MRI contraindications as per usual clinical care, such as (possible)
- •pregnancy, claustrophobia and metal or electronic implants not compatible with
研究者
相似试验
已完成
Unknown
An observational study after completion of a multicenter open-label uncontrolled trial in pleurodesis for secondary intractable pneumothorax with sterile graded talcPatients who participated in an investigator-initiated phase II study in pleurodesis for secondary intractable pneumothorax with sterile graded talc (protocol number: J-TALC2) with absence of chest tube removal within 30 days after pleurodesis, and who still have been hospitalized.JPRN-jRCT1091220271ational Hospital Organization Nagoya Medical Center Hideo Saka30
招募中
不适用
Benefits of Standard ONS in Indian AdultsCTRI/2019/05/018917Abbott Healthcare Pvt Ltd
尚未招募
Unknown
Effect of Sucralfate as a prophylactic agent for stress ulcer in ICU settingsCTRI/2024/01/061168Fourrts India Laboratories Pvt Ltd
招募中
Unknown
To assess the effectiveness of different antibiotics in lung and blood infections caused by carbapenem resistant bacteriaCTRI/2024/02/062846Dr Deepak Govil
招募中
不适用
Observational study to assess data from the past related to the rate of hospitalization inPatients with Schizophrenia treated one year before with oral drugs for Schizophrenia andone year after with injectable drugs for SchizophreniaRBR-2x86dcniversidade Federal de São Paulo - UNIFESP/EPM
